Regenerative Medical Technology Group Inc. financial data

Symbol
RMTG on OTC
Location
433 Plaza Real Suite 275, Boca Raton, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.2 % -78.2%
Debt-to-equity -113 % +29.7%
Return On Equity 43.7 % -5.33%
Return On Assets -329 % -336%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.5M shares
Common Stock, Shares, Outstanding 12.5M shares +0.36%
Entity Public Float 613K USD 0%
Common Stock, Value, Issued 12.5K USD +0.36%
Weighted Average Number of Shares Outstanding, Basic 12.5M shares +0.36%
Weighted Average Number of Shares Outstanding, Diluted 12.5M shares +0.36%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 984K USD +24%
Cost of Revenue 398K USD +49.3%
General and Administrative Expense 207K USD -20.8%
Operating Income (Loss) -250K USD -16.9%
Nonoperating Income (Expense) -1.06M USD +43.3%
Net Income (Loss) Attributable to Parent -1.31M USD +37.1%
Earnings Per Share, Basic -0.1 USD/shares +41.2%
Earnings Per Share, Diluted -0.1 USD/shares +41.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.61M USD
Inventory, Net 106K USD +1482%
Assets, Current 1.91M USD +178%
Property, Plant and Equipment, Net 504K USD +40%
Operating Lease, Right-of-Use Asset 273K USD +153%
Intangible Assets, Net (Excluding Goodwill) 110K USD -46.9%
Goodwill 1.68M USD 0%
Other Assets, Noncurrent 7.26K USD 0%
Assets 4.49M USD +47.1%
Accounts Payable, Current 1.27M USD +202%
Accrued Liabilities, Current 12.4M USD
Contract with Customer, Liability, Current 122K USD -67.3%
Liabilities, Current 30.5M USD +15.6%
Operating Lease, Liability, Noncurrent 209K USD +553%
Liabilities 33.5M USD +16%
Retained Earnings (Accumulated Deficit) -69.6M USD -5.44%
Stockholders' Equity Attributable to Parent -29M USD -12.3%
Liabilities and Equity 4.49M USD +47.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 57.1K USD -47.1%
Net Cash Provided by (Used in) Financing Activities -9.85K USD -606%
Net Cash Provided by (Used in) Investing Activities -59.2K USD -978%
Common Stock, Shares Authorized 100M shares -98.5%
Common Stock, Shares, Issued 12.5M shares +0.36%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.56K USD +98.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.61M USD +162%
Deferred Tax Assets, Valuation Allowance 6.01M USD +13.5%
Operating Lease, Liability 273K USD +153%
Depreciation 27.4K USD -47.4%
Payments to Acquire Property, Plant, and Equipment 59.2K USD +978%
Lessee, Operating Lease, Liability, to be Paid 312K USD +174%
Property, Plant and Equipment, Gross 170K USD
Operating Lease, Liability, Current 64.2K USD -15.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 68.7K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 66.1K USD -13.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 38.9K USD +551%
Lessee, Operating Lease, Liability, to be Paid, Year Three 71.5K USD
Deferred Tax Assets, Operating Loss Carryforwards 6.01M USD +13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 74.3K USD
Additional Paid in Capital 40.6M USD +1%
Amortization of Intangible Assets 24.4K USD 0%
Depreciation, Depletion and Amortization 76.6K USD +35.2%